KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Treasury Shares: 2020-2024

Historic Treasury Shares for Supernus Pharmaceuticals (SUPN) over the last 5 years, with Dec 2024 value amounting to $378,165.

  • Supernus Pharmaceuticals' Treasury Shares fell 1.43% to $397,543 in Q3 2025 from the same period last year, while for Sep 2025 it was $397,543, marking a year-over-year decrease of 1.43%. This contributed to the annual value of $378,165 for FY2024, which is 26.00% up from last year.
  • As of FY2024, Supernus Pharmaceuticals' Treasury Shares stood at $378,165, which was up 26.00% from $300,141 recorded in FY2023.
  • Supernus Pharmaceuticals' Treasury Shares' 5-year high stood at $378,165 during FY2024, with a 5-year trough of $26,055 in FY2020.
  • In the last 3 years, Supernus Pharmaceuticals' Treasury Shares had a median value of $300,141 in 2023 and averaged $293,352.
  • Data for Supernus Pharmaceuticals' Treasury Shares shows a peak YoY surged of 242.06% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Treasury Shares stood at $26,055 in 2020, then skyrocketed by 242.06% to $89,125 in 2021, then spiked by 126.37% to $201,750 in 2022, then spiked by 48.77% to $300,141 in 2023, then grew by 26.00% to $378,165 in 2024.